HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Pharmacological correction of testosterone deficiency during experimental myocardial ischemia.

Abstract
Experiments on rats with myocardial ischemia modeled by occlusion of the left coronary artery aggravated by alimentary dislipoproteinemia showed that therapy with taurepar (50 mg/kg), a taurine derivative, decreased blood corticosterone concentration and increased the level of endogenous testosterone, which attests to normalization of the compensatory-adaptive and gonadotropic functions of the organism.
AuthorsL K Khnychenko, I V Okunevich, Yu O Fedotova, N S Sapronov
JournalBulletin of experimental biology and medicine (Bull Exp Biol Med) Vol. 149 Issue 5 Pg. 601-3 (Oct 2010) ISSN: 1573-8221 [Electronic] United States
PMID21165397 (Publication Type: Journal Article)
Chemical References
  • Dietary Fats
  • taurepar
  • Taurine
  • Testosterone
  • Corticosterone
Topics
  • Animals
  • Corticosterone (blood)
  • Dietary Fats (administration & dosage)
  • Dyslipidemias (drug therapy)
  • Male
  • Myocardial Ischemia (complications, physiopathology)
  • Rats
  • Taurine (analogs & derivatives, therapeutic use)
  • Testosterone (blood, deficiency)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: